MUC1 and neoplasm: Confirming our hypothesis, neutralizing TGF-β treatment in high-MUC1 HPAFII tumors significantly reduced tumor progression and reduced tumor burden (Figure 5B), whereas the same treatment almost hastened tumor growth in low MUC1 MiaPaca2 tumors (Figure 5B).